Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sexual health
Health Tech
Hims & Hers downplays business impact of compounded GLP-1s
Hims & Hers is also facing an investigation from the Securities and Exchange Commission, as revealed in a regulatory filing earlier this week.
Heather Landi
Feb 25, 2026 1:30pm
Wisp acquires TBD Health to accelerate B2B strategy
Jan 27, 2026 9:30am
SCOTUS upholds Tennessee ban on transgender care for youth
Jun 18, 2025 11:55am
Forge Health, TBD Health team up to expand access to free PrEP
Feb 12, 2025 11:43am
